D. Crawford

498 total citations
18 papers, 334 citations indexed

About

D. Crawford is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, D. Crawford has authored 18 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Oncology and 5 papers in Genetics. Recurrent topics in D. Crawford's work include Breast Cancer Treatment Studies (7 papers), Estrogen and related hormone effects (5 papers) and Breast Lesions and Carcinomas (4 papers). D. Crawford is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Estrogen and related hormone effects (5 papers) and Breast Lesions and Carcinomas (4 papers). D. Crawford collaborates with scholars based in United Kingdom, Spain and United States. D. Crawford's co-authors include David C. Smith, Kenneth C. Calman, Ludger Barthelmes, D. Hole, C S McArdle, R E Leake, Fergus Macbeth, Evelyn H. Dykes, D.G. MacDonald and P J Lamey and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and British journal of surgery.

In The Last Decade

D. Crawford

17 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Crawford United Kingdom 9 172 133 99 98 69 18 334
Hiroshi Kaise Japan 12 183 1.1× 228 1.7× 110 1.1× 68 0.7× 36 0.5× 44 420
Kim McManus United States 9 126 0.7× 107 0.8× 94 0.9× 100 1.0× 26 0.4× 10 396
M. Wilt France 6 229 1.3× 221 1.7× 123 1.2× 64 0.7× 32 0.5× 10 351
F. Sciarretta Italy 8 61 0.4× 153 1.2× 48 0.5× 96 1.0× 30 0.4× 17 321
IPM Tomlinson United Kingdom 10 155 0.9× 145 1.1× 264 2.7× 50 0.5× 75 1.1× 10 434
Jean-François Rodier France 10 113 0.7× 112 0.8× 84 0.8× 155 1.6× 99 1.4× 19 402
C. Brumm Germany 7 86 0.5× 155 1.2× 49 0.5× 52 0.5× 98 1.4× 19 332
Luigi Serra Italy 11 69 0.4× 190 1.4× 52 0.5× 101 1.0× 25 0.4× 17 314
Himanshu M Doshi United States 6 73 0.4× 248 1.9× 49 0.5× 59 0.6× 20 0.3× 7 381
Adel K. El Naggar United States 5 88 0.5× 246 1.8× 32 0.3× 206 2.1× 40 0.6× 6 566

Countries citing papers authored by D. Crawford

Since Specialization
Citations

This map shows the geographic impact of D. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Crawford more than expected).

Fields of papers citing papers by D. Crawford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Crawford. The network helps show where D. Crawford may publish in the future.

Co-authorship network of co-authors of D. Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of D. Crawford. A scholar is included among the top collaborators of D. Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Crawford. D. Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Salazar, Ramón, Robert J. Jones, Ana Oaknin, et al.. (2012). A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 70(5). 673–681. 17 indexed citations
3.
Baird, Richard D., B. Venugopal, Montserrat Blanco-Codesido, et al.. (2011). A first-in-human phase I study of JNJ-26481585, a novel oral histone deacetylase inhibitor (HDACi), in patients with advanced cancer with evidence of target modulation and antitumor activity.. Journal of Clinical Oncology. 29(15_suppl). 3024–3024. 1 indexed citations
5.
Postel‐Vinay, Sophie, Peter C.C. Fong, B. Venugopal, et al.. (2009). Preliminary results of an open-label phase I pharmacokinetic/pharmacodynamic study of JNJ26481585: Early evidence of antitumor activity. Journal of Clinical Oncology. 27(15_suppl). e13504–e13504. 2 indexed citations
6.
Evans, T. R. J., Ana Oaknin, Robert J. Jones, et al.. (2009). Phase I dose-escalating study of PM02734 in a 24-hour infusion schedule every 21 days in advanced solid tumors. Journal of Clinical Oncology. 27(15_suppl). 2511–2511. 1 indexed citations
7.
Barthelmes, Ludger, et al.. (2006). Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery. European Journal of Surgical Oncology. 32(7). 729–732. 23 indexed citations
8.
Evans, T. R. J., Annick D. Van den Abbeele, Iain McPherson, et al.. (2005). Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3034–3034. 26 indexed citations
9.
Barthelmes, Ludger, et al.. (2003). Effect of cavity margin shavings to ensure completeness of excision on local recurrence rates following breast conserving surgery. European Journal of Surgical Oncology. 29(8). 644–648. 32 indexed citations
10.
Barthelmes, Ludger, et al.. (2002). The role of lymph node sampling and radiotherapy in the management of the axilla in early breast cancer. The Breast. 11(3). 236–240. 3 indexed citations
11.
Crawford, D., David W. George, David C. Smith, et al.. (1994). Cyclic Sequential Endocrine Therapy for Advanced Breast Cancer Using a Combination of Tamoxifen and Megestrol Acetate. Oncology. 51(1). 13–18. 4 indexed citations
12.
Crawford, D., W.D. George, David C. Smith, et al.. (1992). Comparison of cyclical tamoxifen and megestrol acetate with tamoxifen alone in advanced breast cancer. The Breast. 1(1). 35–40. 4 indexed citations
13.
Lamey, P J, et al.. (1989). Necrotising sialometaplasia presenting as greater palatine nerve anaesthesia. International Journal of Oral and Maxillofacial Surgery. 18(2). 70–72. 16 indexed citations
14.
Crawford, D., Colin Mackay, & R A Burnett. (1988). Haemorrhage from an Adhesion-Related Mesenteric Varix in a Patient with Portal Hypertension. Scottish Medical Journal. 33(3). 271–273. 3 indexed citations
15.
Cunningham, Alfred B., D. Crawford, & William G. Characklis. (1988). Modeling Microbial Transport in Porous Media. Water Science & Technology. 20(11-12). 509–511. 5 indexed citations
16.
McArdle, C S, D. Crawford, Evelyn H. Dykes, et al.. (1986). Adjuvant radiotherapy and chemotherapy in breast cancer. British journal of surgery. 73(4). 264–266. 86 indexed citations
18.
Leake, R E, et al.. (1981). Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability. British Journal of Cancer. 43(1). 59–66. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026